
    
      A retrospective analysis of the previous 10 years, from 2002 to 2011 will be conducted. This
      study will better understand the epidemiology of these complications but also allow to
      identify risk factors associated, including demographic, environmental and related to
      immunosuppressive therapy.

      Thereafter, we hope to implement preventive measures or prospective studies, allowing us to
      reduce the prevalence of this complication.
    
  